Gujarat Inject (Kerala) proposes 3,00,00,000 preferential equity warrants
Board approves proposal to issue 3,00,00,000 Equity Warrants of face value Rs 1 each, aggregating up to Rs 3,00,00,000, on a preferential basis to non‑promoter investors.
Key takeaways
- 3,00,00,000 Equity Warrants of face value Rs 1 each proposed on a preferential basis.
- Rs 3,00,00,000 is the aggregate amount for the proposed Equity Warrants issue.
- 18 months is the period to apply for one Equity Share of face value of Rs.1/- per Warrant.
- ₹15,00,00,000 authorised share capital proposed to rise to ₹17,63,48,000.
- Eleven (11) non‑promoter investors are named in Annexure-B for the warrants.
Key terms
- Action
- Other
- Terms
- 3,00,00,000 Equity Warrants of face value Rs 1 each
- Issue price to be determined as per Chapter V of SEBI ICDR Regulations, 2018
- Conversion option available within 18 months from date of warrant allotment
Gujarat Inject (Kerala) Limited has told the stock exchange that its board has approved a proposal to raise funds through a preferential issue of Equity Warrants, subject to shareholder and regulatory approvals.
This filing is not about a buyback, bonus issue or dividend; it is a proposal to issue convertible warrants to selected non‑promoter investors.
Key terms (as per the board's outcome letter and Annexure A/B)
- Type of instrument: Equity Warrants for cash, with a right to apply for and get allotted one Equity Share of face value of Rs. 1/- each for each Warrant.
- Number of warrants: 3,00,00,000 (Three Crore) Equity Warrants of face value of Rs.1.00/- each.
- Aggregate amount: Up to Rs. 3,00,00,000/-(Rupees Three Crore).
- Face value: Rs 1 per Equity Warrant / Equity Share.
- Issue type: Preferential allotment to Non-promoter/Public Category of the company, in accordance with the SEBI ICDR Regulations and other applicable laws.
- Pricing: The issue price shall be determined in accordance with the pricing guidelines set out under Chapter V of SEBI ICDR Regulations, 2018 and other applicable regulations, if any. The filing does not state a specific price per warrant.
- Conversion terms: Each Equity Warrant carries a right to apply for and get allotted one Equity Share of face value of Rs.1/- each for each Warrant, within a period of 18 (Eighteen) months from the date of allotment of warrants, in one or more tranches. Option for conversion is available only upon payment of full price of the Equity Warrants.
- Number of investors: Eleven (11) investors, as disclosed in Annexure-B.
According to the outcome letter dated 29.10.2026, the board also approved a proposal to increase the authorised share capital of the company from ₹15,00,00,000 (Rupees Fifteen Crore Only) to ₹17,63,48,000 (Rupees Seventeen Crore Sixty-Three Lakh Forty-Eight Thousand Only), representing an increase of ₹2,63,48,000 (Rupees Two Crore Sixty-Three Lakh Forty-Eight Thousand Only). This is stated to be "to facilitate the proposed issue of equity shares of the Company for an aggregate amount of up to ₹3,00,00,000 (Rupees Three Crore Only), taking into consideration the existing paid-up share capital of ₹14,63,48,000 (Rupees Fourteen Crore Sixty-Three Lakh Forty-Eight Thousand Only)", subject to shareholder approval.
Eligibility and investor list
This is a preferential issue, not a rights issue. That means only the named investors in Annexure-B are proposed to receive the Equity Warrants, subject to approvals. Existing retail shareholders who are not part of this list are not eligible to subscribe under this specific proposal.
Annexure-B on page 4 of the filing lists the proposed allottees and the number of warrants for each, including:
- Minaben Shah – 5,00,000 Warrants
- Priyam Surendra Shah – 5,00,000 Warrants
- Priyam Shah Huf – 5,00,000 Warrants
- Pooja Priyam Shah – 5,00,000 Warrants
- Shashank Vyas – 10,00,000 Warrants
- Monal Niranjanbhai Jain – 10,00,000 Warrants
- Ankit Jain – 20,00,000 Warrants
- Ramchandra Dallaram Choudhary – 25,00,000 Warrants
- Yogendrakumar Gupta – 5,00,000 Warrants
- Yogendrakumar Gupta (HUF) – 20,00,000 Warrants
- JV Investment (Partnership Firm - Partner Chunilal S Rathod) – 1,90,00,000 Warrants
The total across these investors is 3,00,00,000 Equity Warrants.
Record date, ex-date and timetable
The filing does not mention any record date, ex-date or detailed timetable for the preferential issue or for any subsequent equity share allotment on conversion of warrants.
The board states that it "proposed to seek Members' approval for the above proposals in due course by way of Extra Ordinary General Meeting of the Company". The date of this Extra-Ordinary General Meeting (EGM) is not provided in the filing.
Company’s stated next steps
The board outcome letter notes that the company will convene an Extra-Ordinary General Meeting to obtain shareholder approval for:
- The increase in authorised share capital and related alteration of the Capital Clause of the Memorandum of Association.
- The preferential issue of Equity Warrants to the identified non‑promoter investors.
The meeting on 29.10.2026 commenced at 9:40 P.M. and concluded at 10:30 P.M., as recorded in the letter signed by Murli Shivshankaran Nair, Whole Time Director (DIN: 02243039).
For retail investors searching for buyback, bonus or dividend details, this filing does not announce any buyback, bonus issue, or dividend, and does not specify any record date related to such actions.
Track Gujarat Inject Kerala Ltd
Cruxal reads every Gujarat Inject Kerala Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
